| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/03/2005 | CA2531400A1 Insecticidal proteins secreted from bacillus thuringiensis and uses therefor |
| 03/03/2005 | CA2531146A1 Compositions of orthogonal lysyl-trna and aminoacyl-trna synthetase pairs and uses thereof |
| 03/02/2005 | EP1510580A2 Novel hepatitis C E1 and E2 truncated polypeptides and methods of obtaining the same |
| 03/02/2005 | EP1510579A2 Use of heregulin as an epithelial cell growth factor |
| 03/02/2005 | EP1509609A1 Protein hydrolysate rich in tripeptides |
| 03/02/2005 | EP1509606A1 Allergen from mugwort pollen |
| 03/02/2005 | EP1509541A2 Novel recombinant anticoagulant proteins |
| 03/02/2005 | EP1509540A2 Claudin polypeptides, polynucleotides, and methods of making and use thereof |
| 03/02/2005 | EP1509253A1 Chimeric cd154 |
| 03/02/2005 | EP1421115B1 Soluble t cell receptor |
| 03/02/2005 | EP1299327A4 Phosphorylated polypeptides and uses related thereto |
| 03/02/2005 | EP1185656B1 Use of the bnm3 transcriptional activator to control plant embryogenesis and regeneration processes |
| 03/02/2005 | EP1141294B1 Method of enhancing the biological activity of ligands |
| 03/02/2005 | EP1115852B1 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells |
| 03/02/2005 | EP1012319B1 Insect expression vectors |
| 03/02/2005 | EP0979244B1 Novel cyclosporin derivatives, preparation and pharmaceutical compositions containing same |
| 03/02/2005 | EP0977881B1 Expression of a modified foamy virus envelope protein |
| 03/02/2005 | EP0976764B1 Novel membrane-secreted protein |
| 03/02/2005 | EP0919617B1 Anti-human mp52 monoclonal antibody |
| 03/02/2005 | EP0907731B1 Metabotropic gaba(b) receptors, receptor-specific ligands and their uses |
| 03/02/2005 | EP0846164B1 Method for assaying in vitro the proteolytic activity of polypeptides having hcv ns3 protease activity and peptide substrates to be used in this method. |
| 03/02/2005 | EP0799311B1 Human chemokine beta-9 |
| 03/02/2005 | EP0797591B1 A novel chemokine expressed in inflamed adenoid, its production and uses |
| 03/02/2005 | EP0690916B1 Pesticidal proteins and strains |
| 03/02/2005 | CN1589328A Process for preparing insulin compounds |
| 03/02/2005 | CN1587399A Producing new fibrinolysin from rhizopchin |
| 03/02/2005 | CN1587385A High efficiency experssino human glicentin-1 gene engineering bacteria and its construction method and use |
| 03/02/2005 | CN1587384A Antibiotic peptide gene converted viscons bacillus engineering bacterium and its preparing method and use |
| 03/02/2005 | CN1191371C Process for preparing easy body absorption protein iron and health food produced therefrom |
| 03/02/2005 | CN1191362C Streptococcus antigens |
| 03/02/2005 | CN1191361C Carrot anti-freeze polypeptides |
| 03/02/2005 | CN1191360C Modified clotting factor VIII |
| 03/02/2005 | CN1191276C Humanized antibodies and method for forming same |
| 03/02/2005 | CN1191275C Antifucoidan polysacchearide antibody |
| 03/02/2005 | CN1191271C Thymic peptide fusion protein as one new interferon and its prepn. |
| 03/02/2005 | CN1191270C Cellulose binding domain |
| 03/02/2005 | CN1191269C Pseudomycin natural product |
| 03/01/2005 | US6861505 Method for recovering soluble protein |
| 03/01/2005 | US6861403 Generating soluble active recombinat proteins; obtain vector, insert preferential binding domain into vector, transform cell, propagate induce expresion of recombinant protein |
| 03/01/2005 | US6861399 Cleaning compositions containing human serine protease T |
| 03/01/2005 | US6861237 Production of heterologous polypeptides in yeast |
| 03/01/2005 | US6861236 Harvesting antibiotic peptides comprising transport protein leader sequences |
| 03/01/2005 | US6861220 Genetic screening methods |
| 03/01/2005 | CA2346257C Method for obtaining active .beta.-ngf |
| 03/01/2005 | CA2237120C Compositions and methods for producing heterologous polypeptides in pichia methanolica |
| 03/01/2005 | CA2133326C Fusion proteins comprising tumor necrosis factor receptor |
| 03/01/2005 | CA2085719C Process for obtaining insulin-containing solutions |
| 02/24/2005 | WO2005017174A2 Process for the purification of recombinant polypeptides |
| 02/24/2005 | WO2005017166A1 Method for the production of a lysate used for cell-free protein biosynthesis |
| 02/24/2005 | WO2005017155A1 Fucose transporter |
| 02/24/2005 | WO2005017149A1 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 02/24/2005 | WO2005017116A2 Thermostable peroxide-driven cytochrome p450 oxygenase variants and methods of use |
| 02/24/2005 | WO2005017102A2 Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins |
| 02/24/2005 | WO2005017093A2 Polypeptides of streptococcus pyogenes |
| 02/24/2005 | WO2005016956A1 Method for detecting transient ligand interactions |
| 02/24/2005 | WO2005016232A2 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 02/24/2005 | WO2004085664A3 Process for the preparation of angiotensin converting enzyme (ace) inhibitors and its use |
| 02/24/2005 | WO2004024088A3 Design of chemokine analogs for the treatment of human diseases |
| 02/24/2005 | WO2003083043A3 Methods for producing secreted polypeptides having l-asparaginase activity |
| 02/24/2005 | WO2003074678A3 Modular recombinatorial display libraries |
| 02/24/2005 | WO2003053921A3 Mutant proteinase inhibitors and uses thereof |
| 02/24/2005 | US20050044406 Adaptive behavioral intrusion detection systems and methods |
| 02/24/2005 | US20050043530 Seminal vesicle tissue-specific promoters and uses thereof |
| 02/24/2005 | US20050043528 Enterococcus faecalis polynucleotides and polypeptides |
| 02/24/2005 | US20050043521 Recovering viral particle and using single chain Fv antibodies specific for subsets of blood leukocytes to isolate and detect blood and fetal bone marrow cells |
| 02/24/2005 | US20050043520 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/24/2005 | US20050043519 Generating immunoglobulin specific to novel antigen receptor (NAR) for use in innunodiagnostic and immunotherapy |
| 02/24/2005 | US20050043518 Monoclonal antibody for use in detection of plant protein associated with natural rubber; diagnosing latex allergies and hypersensitivity |
| 02/24/2005 | US20050043517 Method for generating antibodies |
| 02/24/2005 | US20050043516 TACI antibodies and uses thereof |
| 02/24/2005 | US20050043514 Monoclonal antibody recognizing phosphatidylinositol-3,4-diphosphate |
| 02/24/2005 | US20050043421 Reducing concentration of amine polymerization catalyst; polyurethane foams |
| 02/24/2005 | US20050043243 Polypeptide for use in treatment of energy balance defects, energy balance involving energy metabolism, nutritional state, lipid storage and the like, food intake and metabolism of carbohydrates and lipids to generate energy |
| 02/24/2005 | US20050043241 Use of inhibitors of given amino acid sequence; inhibit phosphorylation of a transcription factor; can be used to treat or prevent diabetes, ionizing radiation damage, autoimmune diseases, ischemia/reperfusion injuries, heart hypertrophies, cancer |
| 02/24/2005 | US20050042738 Carbohydrate-associated proteins |
| 02/24/2005 | US20050042735 Metabolic engineering for enhanced production of chitin and chitosan in microorganisms |
| 02/24/2005 | US20050042731 Four helical bundle cytokine family polypeptide for use in treatment, diagnosis and prevention of infection, cardiovascular, metabolic, developmental, skin, bone, inflammatory and autoimmune disorders |
| 02/24/2005 | US20050042730 Gene screening method using nuclear receptor |
| 02/24/2005 | US20050042729 Expression vector comprising nucleotide sequences conding immunoglobulin/interferon fusion for use in targeting and treatment of liver disorders |
| 02/24/2005 | US20050042721 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 02/24/2005 | US20050042718 Using transgenic cells to generate monoclonal antibodies for use in immunodiagnostics and tissue directed therapy |
| 02/24/2005 | US20050042701 Bioconjugates; metabolites; kits; bioavailbility; pharmacokinetics |
| 02/24/2005 | US20050042680 Single chain antigen-binding polypeptides for polymer conjugation |
| 02/24/2005 | US20050042669 Combinatorial chemistry |
| 02/24/2005 | US20050042653 Human transport protein homologs |
| 02/24/2005 | US20050042652 Identifying monoclonal antibody for use in prevention and treatment of skin disorers; immunotherapy and peptide mimetics |
| 02/24/2005 | US20050042634 B. anthracis prevention and treatment: mutant B. anthracis lacking luxS activity and furanone inhibition of growth, AI-2 quorum sensing, and toxin production |
| 02/24/2005 | US20050042305 Cutting particle sizes; solvent extraction; reduced ribonuclease activity activation |
| 02/24/2005 | US20050042231 Useful in vaccines, and monoclonal antibodies against said immunogenic surface proteins; hybridoma cell line that produes said antibodies; use in diagnostic kits for determining presence, onset, or decrease in Leptospiral infection |
| 02/24/2005 | US20050042222 Methods of diagnosing thyroid carcinoma |
| 02/24/2005 | US20050042216 Binding monoclonal, humanized, or fragment of antibody to human cell that expresses a protein; cancer |
| 02/24/2005 | US20050042206 Viral vectors having reduced virulence |
| 02/24/2005 | DE20122302U1 Variante des Modifizierten Vaccinia-Ankara-Virus Modified version of the vaccinia Ankara virus |
| 02/24/2005 | CA2535863A1 Polypeptides of streptococcus pyogenes |
| 02/24/2005 | CA2535860A1 Method for detecting transient protein interactions and drug discovery |
| 02/24/2005 | CA2535508A1 A new class of .alpha.2.delta. calcium channel subunits |
| 02/24/2005 | CA2535007A1 Nogo receptor antagonists |
| 02/24/2005 | CA2534563A1 Antibodies to c-met |
| 02/24/2005 | CA2529553A1 Ribonucleases and methods of making them recombinantly |
| 02/24/2005 | CA2526120A1 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |